Result: Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma

*Title*:

*Author/editor-in-chief*:

*Publication*:

Freiburg : Universität, 2021

*Physical description scale*:

Online-Ressource

*Format*:

*eBook*

*Language*:

*eng*

*Notes*:

EMBO molecular medicine
8, 1 (2016) , 39-57, ISSN: 1757-4684

*DOI*:

10.15252/emmm.201505505

*Result*: Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma